The 2026Q2 combined ratio of 82.6% indicates strong underwriting profitability, with the loss ratio at 35.8% and expense ratio at 46.7%. However, the 2025Q4 spike to 88.8% with a loss ratio of 88.0% suggests potential reserve strengthening or catastrophe losses, highlighting volatility. The low loss ratios in recent quarters may be flattered by favorable prior-year reserve development, which could mask deteriorating current accident year trends, especially given social inflation pressures in commercial auto.

The quarterly ROE has been volatile, ranging from 1.5% to 5.6%, with a TTM ROE of 16.2% (annualized). The underwriting margin, derived from the combined ratio, has been consistently positive, averaging around 15% over the last year, which is a key driver of ROE. Investment income on the float also contributes, but with a low D/E of 0.27%, the balance sheet is conservatively leveraged, and the investment portfolio's yield is critical. The Q4 2025 spike in loss ratio suggests that underwriting results can be lumpy, and investors should monitor whether the low loss ratios are sustainable.

The expense ratio has shown a clear downward trend over the past two years, from 54.9% in 2024Q2 to 46.7% in 2026Q2, suggesting that ORI is achieving operating leverage as premiums grow. This improvement is partly due to the variable cost structure in Title Insurance, where agent commissions scale with volume, and also reflects efficiency gains in General Insurance. However, the expense ratio spiked in 2025Q4 to 50.3% (with a loss ratio of 88.0%), indicating that quarter's combined ratio was driven by losses, not expenses. The overall trend suggests management is controlling costs effectively, but the sustainability of this improvement depends on maintaining premium growth.

While the premium-to-surplus ratio is not explicitly disclosed, the extremely low debt-to-equity ratio of 0.27% and a growing equity base of $6.1B suggest that ORI operates with substantial capital cushion relative to its underwriting exposures. This conservative leverage is consistent with the company's historical fiscal prudence and supports its ability to withstand adverse loss developments. However, the Title segment's cyclicality and the potential for reserve inadequacy in long-tail lines warrant monitoring, as a significant deterioration in loss ratios could strain capital if not offset by premium increases.

ORI's valuation multiples are lower than those of pure-play specialty insurers like WRB and TRV, likely due to the market's focus on the cyclical Title segment. The P/B of 1.75 implies a lower ROE expectation than WRB's 2.84, which is justified by ORI's lower ROE (16.2% vs. 19.5% for WRB) and the volatility from Title. However, the General Insurance segment's strong underwriting performance and the Title segment's variable cost structure may warrant a narrower discount. The high dividend yield of 7.5% (including special dividends) provides a floor, but investors should assess whether the discount reflects a permanent structural issue or a temporary mispricing.